Mexiletine Hydrochloride

CHEMBL1200606 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

215.7 g/mol

LogP

—

Phase

4

This is the hydrochloride salt form of mexiletine; see mexiletine for full prescribing information.

Peso molecular

215,7200 g/mol

TPSA

35,30 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1cccc(C)c1OCC(C)N.Cl

InChI

InChI=1S/C11H17NO.ClH/c1-8-5-4-6-9(2)11(8)13-7-10(3)12;/h4-6,10H,7,12H2,1-3H3;1H

Molecular Formula

C11H18ClNO

HBD / HBA

2 / 2

Enlaces Rotables

3

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This is the hydrochloride salt form of mexiletine; see mexiletine for full prescribing information.

Yes, Mexiletine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200606. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 21467. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Mexiletine Hydrochloride en PillFYI

Estructura

Datos Rápidos

Fórmula: C11H18ClNO
Sinónimos: 1

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.